Immunomedics Announces US Patent Issuance For IMMU-114 - Quick Facts RTT News Moreover, in one animal model of human NHL, treatment with the anti-HLA-DR antibody was more effective than rituximab in yielding 100% long-term survival. Click here to receive FREE breaking news email alerts for Immunomedics Inc. and others in your ... |
